US Stock MarketDetailed Quotes
TECX Tectonic Therapeutic
- 18.000
- -0.130-0.72%
Close Jul 30 16:00 ET
265.22MMarket Cap-510P/E (TTM)
18.620High17.463Low14.98KVolume18.440Open18.130Pre Close273.01KTurnover0.25%Turnover RatioLossP/E (Static)14.73MShares19.80052wk High1.48P/B107.62MFloat Cap12.12052wk Low--Dividend TTM5.98MShs Float644.400Historical High--Div YieldTTM6.38%Amplitude6.720Historical Low18.219Avg Price1Lot Size
About Tectonic Therapeutic Company
Tectonic Therapeutic, Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.
Company Profile
SymbolTECX
Company NameTectonic Therapeutic
Listing DateJun 21, 2018
Issue Price19.00
Founded2019
CEODr. Alise S. Reicin, M.D.
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Websitehttp://tectonictx.com/
Company Executives
- Name
- Position
- Salary
- Dr. Alise S. Reicin, M.D.
- Chief Executive Officer and Director
- --
- Dr. Peter McNamara, PhD
- Chief Scientific Officer
- --
- Dr. Marcella Kuhlman Ruddy, M.D.
- Chief Medical Officer
- --
- Dr. Marc Schwabish, PhD
- Chief Business Officer
- --
- Daniel Lochner
- Chief Financial Officer and Principal Accounting Officer
- --
- Terrance McGuire
- Director
- --
- Stefan Vitorovic, M.B.A.,M.S.
- Director
- --
- Dr. Timothy A. Springer, M.D.,PhD
- Director
- --
- Phillip B. Donenberg
- Director
- --
- Dr. Praveen Tipirneni
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg